12/7/22 CC
Cyrus
“18:50: Within oncology, we want to pursue colorectal cancer and breast cancer specifically.
Within the colorectal cancer population, we want to focus on a micro-satellite stable group, which represents about 85% of all diagnosed colorectal cancers. And within breast cancer, we want to focus on the hormone receptor positive HER2-negative population, which is about 70% of all diagnosed breast cancers, and the TNBC population since we have data in that space.”

The “urgent data” in CD07. Wonder what it will show us.